Basic Information
Basic information for MIR9-3HG-222-23aa-3
Peptide Name MIR9-3HG-222-23aa-3
Genome Position chr15:89397815-89397883[+]
Species Human
Peptide Sequence MRTPRPRKVKLHVLSHTACKCQN
Peptide Length 23
Unique No (MIR9-3HG-201-23aa-3,MIR9-3HG-212-23aa-3,MIR9-3HG-213-23aa-3,MIR9-3HG-214-23aa-3,MIR9-3HG-218-23aa-3,MIR9-3HG-219-23aa-3,MIR9-3HG-220-23aa-3,MIR9-3HG-221-23aa-3,MIR9-3HG-226-23aa-1,MIR9-3HG-227-23aa-3,MIR9-3HG-233-23aa-4,MIR9-3HG-241-23aa-3,MIR9-3HG-246-23aa-4,MIR9-3HG-247-23aa-3,MIR9-3HG-251-23aa-3,MIR9-3HG-252-23aa-4,MIR9-3HG-253-23aa-3)
Grand Average of Hydropathicity -0.8391
Relative Molecular Mass 3100.69
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000659235;MIR9-3HG-222
Transcript Length 4269
Coding Ability 0.5011
DNA Sequence Corresponding to Peptide ATGAGGACACCGAGGCCCAGAAAAGTTAAGTTACATGTCCTAAGTCACACAGCTTGTAAGTGCCAGAAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :